News_Details

PHEXCOM

Solution BY Communication

>>Back

FDA nixes new gout use for Regeneron's Arcalyst

Publisher：
Publication：2012/8/1

The FDA dashed Regeneron's ($REGN) immediate hopes for a vast expansion of its anti-inflammatory drug Arcalyst. The drugmaker had been aiming to market Arcalyst to prevent gout flare-ups, but the agency asked for more clinical data.

Excipients

oleaginous vehicle
flavoring agent
viscosity-increasing agent
suspending agent
disintegrant
thickener
solvent
alkalizing agent
chelating agent
emulsifying agent
buffer
adhesive
coating agent
sweetening agent
film-former
gelling agent
solublizing agent
diluent
preservative
carrier